- Novel Substituted Monocyclic Heteroaryl Compounds for Treating Huntington's Disease.
- Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease.
- Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
- Kinetics of Fast Tetramerization of the Huntingtin Exon 1 Protein Probed by Concentration-Dependent On-Resonance R1ρ Measurements.
- Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1.
- Defective Autophagy and Mitophagy in Aging and Alzheimer's Disease.
- Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).
- The use of wearable/portable digital sensors in Huntington's disease: A systematic review.
- Benefit of long-acting paliperidone in Huntington's disease: a case report.
- Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.
- The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases.
- Neurologists' current practice and perspectives on communicating the diagnosis of a motor neurodegenerative condition: a UK survey.
- Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.
- Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease.
- Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration.
- Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
- [Recurrent psychotic symtoms over several years were caused by Huntington's disease].
- Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.
- Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting.
- Mitophagy Impairment in Neurodegenerative Diseases: Pathogenesis and Therapeutic Interventions.
- Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression.
- Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease.
- PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.
- Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden.
- Htt is a repressor of Abl activity required for APP-induced axonal growth.
- Late-onset Huntington's disease with 40-42 CAG expansion.
- Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation.
- Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction.
- Recent advances in enzymeless-based electrochemical sensors to diagnose neurodegenerative diseases.
- Past, present and future role of retinal imaging in neurodegenerative disease.
- Monitoring the Motor Phenotype in Huntington's Disease by Analysis of Keyboard Typing During Real Life Computer Use.
- Neuroprotective Effects of Heat-Killed Lactobacillus plantarum 200655 Isolated from Kimchi Against Oxidative Stress.
- AggreCount: an unbiased image analysis tool for identifying and quantifying cellular aggregates in a spatially defined manner.
- Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases.
- Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration.
- Prepubertal exposure to a high dose of cadmium induces hypothalamic injury through transcriptome profiling alteration and neuronal degeneration in female rats.
- HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.
- Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.
- Reprint of: Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease.
- Discovery of the First Druggable GPR52 Antagonist to Treat Huntington's Disease.
- Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity.
- FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model.
- Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington's disease mice.
- Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140/Q140 mouse model of Huntington's disease.
- Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
- CYC1, SDHA, UQCRC1, UQCRQ, and SDHB might be important biomarkers in kidney transplant rejection.
- Pathogenesis of SCA3 and implications for other polyglutamine diseases.
- Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders.
- Gaining insight into the views of outpatients with Huntington's disease regarding their future and the way they deal with their poor prognosis: a qualitative study.
- Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases.
RSS Feed – Literature
HDinHD > RSS Feed – Literature
